Epicentre of Covid

India needs a national action plan

Coronavirus
A medic stores samples for COVID-19 rapid antigen testing amid the complete bi-weekly lockdown to curb COVID-19 spread
Business Standard Editorial Comment
3 min read Last Updated : Aug 11 2020 | 1:28 AM IST
India has now become the epicentre of Covid-19, with the maximum number of daily cases happening in this country, and there are no signs of the curve flattening, unlike in most other countries. The data shows that the number of new cases is now slowing both in the US and Brazil. India has crossed the 2 million mark in terms of the number of cases and is now recording more than 60,000 daily infections. The data also suggests that things are unlikely to improve in the near term. Although India has increased the capacity to test about 700,000 samples a day, it is not enough. The positivity rate continues to remain high, which indicates that the problem is only going to get bigger. Even as the load has moderated in large cities, Covid is now spreading in other parts of the country, including rural areas. It would be more difficult to contain the virus in rural areas because of the lack of medical and state capacity.

Given the magnitude of the problem, it is strange that no one in the government is saying anything about it, as though the problem does not exist or has not grown to proportions previously unimagined. There are no daily briefings, no announcement of lengthening “doubling rates”, offering hope. Further, it is not clear as to who is in charge of handling the situation. It was the health minister initially, with significant interventions from the prime minister and his office. Then it was the home minister, especially when things were slipping out of control in Delhi. There is no clarity on who is in charge now. The collective intervention significantly improved things in the city-state. However, it is not clear if India has a national plan to deal with the Covid crisis, or states have now been left to handle things on their own.

It is important to note that apart from being a health crisis, surging infection is coming in the way of economic revival because of local lockdowns and disrupted supply chains. The incoming high-frequency data suggests that economic recovery is faltering. The resumption of business tracked by Nomura through an index, for instance, shows that activity is stuck at about 30 percentage points below the pre-pandemic level, after witnessing a sharp recovery in May and June. The continued spread of the virus will only increase complications on the economic front. 

Sustained localised lockdown or, perhaps, an increase in its frequency and spread would further restrict movement and affect both demand and supply. A deeper than expected contraction will only make things worse. India, therefore, needs a broader strategy to deal with the evolving situation, and the Centre will need to take the lead. It will need to coordinate with states where cases are rising. The issue of finances also needs to be addressed, as states, being on the front line of fighting the pandemic, would need resources. Thus, all possible instruments to bridge the revenue shortfall should be discussed transparently, so that states have better clarity. Overall, since a possible vaccine is still some distance away, India needs renewed focus on containing the pandemic. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story